Nectar Lifesciences Limited (NSE:NECLIFE)

Nectar Lifesciences Revenue

Nectar Lifesciences had revenue of 6.61M INR in the quarter ending December 31, 2025, a decrease of -99.85%. This brings the company's revenue in the last twelve months to 16.70B, down -0.66% year-over-year. In the fiscal year ending March 31, 2025, Nectar Lifesciences had annual revenue of 16.70B, down -0.84%.

• Revenue (ttm): 16.70B
• Revenue Growth: -0.66%
• P/S Ratio: 0.17
• Revenue / Employee: 9.35M
• Employees: 1,786
• Market Cap: 2.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	16.70B	-142.05M	-0.84%
Mar 31, 2024	16.85B	1.61B	10.56%
Mar 31, 2023	15.24B	-1.45B	-8.70%
Mar 31, 2022	16.69B	1.26B	8.13%
Mar 31, 2021	15.43B	-8.23B	-34.78%